1. Scrip
  2. >>Business
  3. >>Start-Ups & SMEs

Evox To Raise Cash In 2018 For Novel Exosome Platform

 
• By Lucie Ellis-Taitt

Emerging Company Profile: Evox Therapeutics – a privately held, Oxford-based biotechnology company developing a new class of biotherapeutics called exosomes – is using its technology to improve the delivery of validated therapies, particularly targeting central nervous system and neuromuscular conditions.

Emerging Company Profile Regular column feature image Version 2
Evox teams up with Boehringer to develop exosome-mediated RNA drugs

Evox Therapeutics, a 2016-founded biotech based on novel exosome technology from Oxford University and the Karolinska Institute, expects to raise "substantial" funds in 2018 to progress its early-stage research into the clinic.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Start-Ups & SMEs

More from Business